Patents by Inventor Manjunatha M. Venkataswamy

Manjunatha M. Venkataswamy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
    Patent number: 9139809
    Abstract: The invention is directed compositions and methods related to bacterial cells physically associated with ceramide-like glycolipids. The invention allows for delivery of ceramide-like glycolipid adjuvants directly to the same cells that become infected with a bacterial vaccine. The compositions and methods of the present invention are useful for the prevention and treatment of diseases.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: September 22, 2015
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Steven A. Porcelli, Manjunatha M. Venkataswamy
  • CERAMIDE-LIKE GLYCOLIPID-ASSOCIATED BACTERIAL VACCINES AND USES THEREOF
    Publication number: 20130164325
    Abstract: The invention is directed compositions and methods related to bacterial cells that are physically associated with ceramide-like glycolipids for use as antigen carriers for heterologous antigens. The invention further relates to methods of incorporating ceramide-like glycolipid to bacterial cell walls. The compositions and methods of the present invention are useful for the prevention and treatment of diseases.
    Type: Application
    Filed: July 6, 2011
    Publication date: June 27, 2013
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Steven A. Porcelli, Manjunatha M. Venkataswamy
  • BACTERIAL VACCINES WITH CELL WALL-ASSOCIATED CERAMIDE-LIKE GLYCOLIPIDS AND USES THEREOF
    Publication number: 20100183549
    Abstract: The invention is directed compositions and methods related to bacterial cells physically associated with ceramide-like glycolipids. The invention allows for delivery of ceramide-like glycolipid adjuvants directly to the same cells that become infected with a bacterial vaccine. The compositions and methods of the present invention are useful for the prevention and treatment of diseases.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 22, 2010
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Steven A. Porcelli, Manjunatha M. Venkataswamy